Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.

Garg N, Zivadinov R, Ramanathan M, Vasiliu I, Locke J, Watts K, Lema J, Rajeswary J, Munschauer FE, Ambrus J Jr, Weinstock-Guttman B.

J Neuroimmunol. 2007 Jul;187(1-2):159-65. Epub 2007 May 18.

PMID:
17512610
2.

Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature.

Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR.

Medicine (Baltimore). 2000 Jan;79(1):57-68. Review.

3.

Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.

Link H, Huang YM.

J Neuroimmunol. 2006 Nov;180(1-2):17-28. Epub 2006 Sep 1. Review.

PMID:
16945427
4.

Clinically isolated syndromes: predicting and delaying multiple sclerosis.

Thrower BW.

Neurology. 2007 Jun 12;68(24 Suppl 4):S12-5. Review.

PMID:
17562845
5.

Relating relapse and T2 lesion changes to disability progression in multiple sclerosis: a systematic literature review and regression analysis.

Fahrbach K, Huelin R, Martin AL, Kim E, Dastani HB, Rao S, Malhotra M.

BMC Neurol. 2013 Nov 19;13:180. doi: 10.1186/1471-2377-13-180. Review.

6.

The interface of multiple sclerosis and antiphospholipid antibodies.

Chapman J.

Thromb Res. 2004;114(5-6):477-81. Review.

PMID:
15507281
7.

Statistical issues related to the use of MRI data in multiple sclerosis.

Sormani MP, Filippi M.

J Neuroimaging. 2007 Apr;17 Suppl 1:56S-59S. Review.

PMID:
17425737
8.

[The use of magnetic resonance imaging in the study of asymptomatic familial multiple sclerosis patients].

Barakat Shrem O, Fernández Pérez MJ, Benavente Fernández A, García Moreno JM, Ruiz Peña JL, Fajardo Galvez J, Izquierdo G.

Rev Neurol. 2003 Nov 1-15;37(9):811-4. Review. Spanish.

9.

Increasing benefit of magnetic resonance imaging in multiple sclerosis.

Pyhtinen J, Karttunen A, Tikkakoski T.

Acta Radiol. 2006 Nov;47(9):960-71. Review.

PMID:
17077049
10.

Early treatment of multiple sclerosis: a Latin American experts meeting.

Garcea O, Villa A, Cáceres F, Adoni T, Alegría M, Barbosa Thomaz R, Buzo R, Llamas López L, Rivera Kindel M.

Mult Scler. 2009 Oct;15 Suppl 3:S1-S12. doi: 10.1177/1352458509106419. Review.

PMID:
19965556
11.

Multiple sclerosis: disease biomarkers as indicated by pathophysiology.

Berger T, Reindl M.

J Neurol Sci. 2007 Aug 15;259(1-2):21-6. Epub 2007 Mar 26. Review.

PMID:
17367811
12.

Antiphospholipid antibodies and pregnancy: maternal implications.

Branch DW.

Semin Perinatol. 1990 Apr;14(2):139-46. Review.

PMID:
2187247
13.

The role of B cells and autoantibodies in multiple sclerosis.

Archelos JJ, Storch MK, Hartung HP.

Ann Neurol. 2000 Jun;47(6):694-706. Review.

PMID:
10852535
14.

Pediatric multiple sclerosis.

Chitnis T.

Neurologist. 2006 Nov;12(6):299-310. Review.

PMID:
17122726
15.

Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature.

Gupta S, Zivadinov R, Ramasamy D, Ambrus JL Jr.

Clin Rheumatol. 2014 Dec;33(12):1829-33. doi: 10.1007/s10067-013-2434-9. Epub 2013 Nov 26. Review.

PMID:
24277114
16.

Auto-antibodies in multiple sclerosis: an hypothesis.

Waegemans T.

Biomed Pharmacother. 2004 Jun;58(5):282-5. Review. No abstract available.

PMID:
15194163
17.

Mri correlates of MS pathologic subtypes.

Moore GR.

Mult Scler. 2005 Feb;11(1):103-5. Review. No abstract available.

PMID:
15732279
18.

Immunologic correlates of MS pathologic subtypes.

Ransohoff RM.

Mult Scler. 2005 Feb;11(1):101-2. Review. No abstract available.

PMID:
15732278

Supplemental Content

Support Center